2025
SJR Q2
JCR Q3 · 3
6 matched articles
SCIE
Journal detail
Regenerative Medicine
- Publisher
- Taylor and Francis Ltd.
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
174607511746076X
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,487
- Quartile Q2
- H-Index 80
- Cites/doc 2,42
- Docs (3y) 205
- Cites (3y) 461
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 3
- 5Y JIF 3,1
- JCI 0,43
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Biomedical Engineering Q3
- Embryology Q2
Areas
- Engineering
- Medicine
WoS categories
- Cell & Tissue Engineering | Engineering, Biomedical
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,487 | 3 | 3,1 | 0,43 | Q3 | 80 |
| 2024 | Q2 | Q3 | 0,509 | 2,6 | 2,8 | 0,44 | Q3 | 77 |
| 2023 | Q2 | Q3 | 0,517 | 2,4 | 2,8 | 0,44 | Q3 | 77 |
| 2022 | Q2 | Q3 | 0,471 | 2,7 | 3 | 0,5 | Q3 | 77 |
| 2021 | Q2 | Q3 | 0,519 | 3,2 | 3,4 | 0,57 | Q3 | 77 |
| 2020 | Q2 | Q2 | 0,572 | 3,8 | 3,5 | 0,61 | Q3 | 77 |
| 2019 | Q2 | Q2 | 0,619 | 2,6 | 2,8 | 0,59 | Q3 | 77 |
| 2018 | — | Q2 | — | 2,4 | 2,6 | 0,61 | Q3 | — |
| 2017 | Q2 | Q2 | 0,887 | 3 | 3 | 0,62 | Q3 | 77 |
| 2016 | Q2 | Q2 | 0,771 | 2,9 | 3,2 | — | — | 77 |
| 2015 | Q2 | Q2 | 0,8 | 2,6 | 3,3 | — | — | 77 |
| 2014 | Q2 | Q2 | 0,903 | 2,8 | 3,6 | — | — | 77 |
| 2013 | Q2 | Q1 | 0,871 | 3,5 | 3,7 | — | — | 77 |
| 2012 | Q1 | Q1 | 0,902 | 3,9 | 3,8 | — | — | 77 |
| 2011 | Q1 | Q1 | 1,035 | 3,7 | 3,2 | — | — | 77 |
| 2010 | Q2 | Q1 | 0,766 | 3,4 | 3,2 | — | — | 77 |
| 2009 | — | Q1 | — | 2,9 | 2,9 | — | — | — |
| 2008 | — | Q1 | — | 2,8 | 2,8 | — | — | — |
| 2007 | — | Q3 | — | 1,2 | 1,2 | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q4 | 21/32 |
| 2025 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 69/130 |
| 2024 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q4 | 22/32 |
| 2024 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 72/124 |
| 2023 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 25/31 |
| 2023 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 73/123 |
| 2022 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 24/29 |
| 2022 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 65/96 |
| 2021 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q3 | 25/29 |
| 2021 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 61/98 |
| 2020 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q3 | 21/29 |
| 2020 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q3 | 37/89 |
| 2019 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q3 | 23/29 |
| 2019 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q3 | 39/87 |
| 2018 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q3 | 21/26 |
| 2018 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q3 | 36/80 |
| 2017 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q3 | 15/24 |
| 2017 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q3 | 22/78 |
| 2016 | CELL & TISSUE ENGINEERING | SCIE | Q3 | — | 15/21 |
| 2016 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 23/77 |
| 2015 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 16/21 |
| 2015 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 20/76 |
| 2014 | CELL & TISSUE ENGINEERING | SCIE | Q3 | — | 13/21 |
| 2014 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 20/76 |
| 2013 | CELL & TISSUE ENGINEERING | SCIE | Q3 | — | 10/18 |
| 2013 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 9/76 |
| 2012 | CELL & TISSUE ENGINEERING | SCIE | Q3 | — | 9/17 |
| 2012 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 7/79 |
| 2011 | CELL & TISSUE ENGINEERING | SCIE | Q3 | — | 7/12 |
| 2011 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 6/72 |
| 2010 | CELL & TISSUE ENGINEERING | SCIE | Q3 | — | 8/13 |
| 2010 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 8/70 |
| 2009 | CELL & TISSUE ENGINEERING | SCIE | Q3 | — | 8/12 |
| 2009 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 12/59 |
| 2008 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 8/52 |
| 2007 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | — | 29/44 |